Congratulations to Matthew Freeby, MD, the first Hunter Eastman Scholar of Translational Diabetes Research, at Columbia University's Naomi Berrie Diabetes Center. This gift to the Berrie Center is already enabling the conduct of important translational diabetes research by fostering collaboration between clinical and basic investigators. Dr. Freeby obtains the biological samples, from carefully characterized subjects with various clinical types of diabetes, that are used by collaborator Dieter Egli, PhD, and colleagues in stem cell research aimed at better understanding the molecular bases for diabetes.
This endowed program provides annual funds for an investigator to work at the interface between basic science and clinical diabetes research within the Naomi Berrie Diabetes Center. The program was established through the James and Irene Hunter Charitable Fund, generously directed to the Berrie Center by Barbara H. Trotta and Katama G. Eastman.
“I’m thrilled to have this honor and the support that comes with it,” said Dr. Freeby, an adult diabetes specialist and clinical investigator. “This program celebrates one of the unique aspects of the Naomi Berrie Center, which is the real partnership between the clinical and research programs.”
Read about Dr. Freeby’s translational diabetes research next week as well as the story behind the Hunter Eastman Translational Research Fund, in our February newsletter.
Pictured above is Dr. Freeby (right) collaborating with Dr. Egli.